← SynDRA
CGS-9896
SynDRA canonical compound SYN0001169 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | GABRA1 | GABRB2 | GABRG2 |
|---|
| Mechanism of action | GABA receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- GABA receptor antagonist
- GABRG2 INHIBITOR
- GABRB2 INHIBITOR
- GABRA1 INHIBITOR
Cross-references
Synonyms
- Cgs 9896
- UNII-86PWQ4PVN0
- 86PWQ4PVN0
- AC1Q3J9C
- AC1L337H
- SCHEMBL7308514
- AC1Q3T13
- 2-(4-chlorophenyl)-1H-pyrazolo[4,3-c]quinolin-3-one
- SCHEMBL17236324
- CTK5E4889
- BDBM84957
- AOB4759
- MolPort-009-714-150
- CQINXWYVIOMBEI-UHFFFAOYSA-N
- PDSP2_001748
- 2-(4-chlorophenyl)-1,2-dihydro-3h-pyrazolo[4,3-c]quinolin-3-one
- PDSP1_001765
- ZINC100367629
- AKOS021973584
- MCULE-9708849911
- A10022
- 2-(p-chlorophenyl)-pyrazolo[4,3-c]quinolin-3(5H)-one
- F3406-4901
- 2-(4-chlorophenyl)-1H-pyrazolo[4,5-c]quinolin-3-one
- SCHEMBL29469727
- 2-(4-chlorophenyl)-3aH-pyrazolo[4,3-c]quinolin-3-one
Look up CGS-9896 in the interactive SynDRA portal →